{
  "author": {
    "name": "Simeon Bennett",
    "webUrl": "/author/profile/simeon-bennett/",
    "description": "",
    "imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
    "estimate": 1,
    "social": [],
    "articles": [
      {
        "uri": "/2015/03/27/novartis-goes-high-tech/",
        "title": "Novartis goes high-tech",
        "byline": "Simeon Bennett",
        "kicker": "",
        "prettyDate": "March 27, 2015",
        "timeToRead": "10 minute",
        "image": {
          "uri": "",
          "width": "",
          "height": ""
        },
        "authors": [
          {
            "webUrl": "/author/profile/simeon-bennett/",
            "name": "Simeon Bennett"
          }
        ],
        "kickerNode": [],
        "summary": "As Novartis AGs chief executive, Jimenez is barreling down untested paths at the frontier of biology and digital technology to prepare for a future in which the use of smartphones and other digital devices to monitor health will be the key to getting paid.",
        "body": null
      }
    ]
  }
}